ClinicalTrials.Veeva

Menu

Integration of Palliative Care in an Oncology and Hematology Unit

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Advanced Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The main goal of this study is to assess retrospectively the integration of Palliative Care in an oncology and hematology unit. The investigators will study the last six month of life on advanced cancer patients and retrieve data from their medical file to obtain criterias of quality of care and integration of palliative care in this population.

Those criterias have been used before in other setting (Earle Criterias, ESMO Recommendations) and The investigators will compare our data to existing publications.

They also hope to see if it is retrospectively possible to assess the probability of death using the Pronopall score. This will help them asses if aggressive end of life care could have been avoided using the Pronopall Score

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged over 18 years old
  • Patient who has been followed in the oncohematology Unit of the University Hospital of Strasbourg for a solid tumor or haematological cancer
  • Died within the 1rst of January 2017 and the 31st of December 2018
  • The patient has not expressed an opposition to the use of his medical data during his lifetime.

Exclusion criteria

  • Patient receiving allogeneic stem cell transplant
  • Patient expressed during his lifetime an opposition regarding the use of his medical data

Trial contacts and locations

1

Loading...

Central trial contact

Gabriel MALOUF, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems